428 related articles for article (PubMed ID: 31648035)
21. Placement of closed-cell designed venous stents in a mixed cohort of patients with chronic venous outflow obstructions - short-term safety, patency, and clinical outcomes.
Lichtenberg M; Breuckmann F; Stahlhoff WF; Neglén P; Rick G
Vasa; 2018 Oct; 47(6):475-481. PubMed ID: 30175948
[TBL] [Abstract][Full Text] [Related]
22. Partial In-Stent Thrombosis After Iliac Vein Stenting in Non-Thrombotic Vein Lesions.
Kibrik P; Arustamyan M; Alsheekh A; Ostrozhynskyy Y; Rabinovich V; Marks N; Hingorani A; Ascher E
Ann Vasc Surg; 2022 Jan; 78():257-262. PubMed ID: 34537349
[TBL] [Abstract][Full Text] [Related]
23. Guidance of Venous Stent Implantation after Catheter-directed Thrombosis in Patients with Acute Left Lower Extremity Deep Venous Thrombosis based on Pressure Gradient Differences between the Iliac Vein and Inferior Vena Cava: A Single-center Retrospective Study.
Che H; Liu G; Yu Y; Sang G; Zhang X
Ann Vasc Surg; 2019 Aug; 59():217-224. PubMed ID: 30802569
[TBL] [Abstract][Full Text] [Related]
24. Long-term clinical outcomes and technical factors with the Wallstent for treatment of chronic iliofemoral venous obstruction.
Gagne PJ; Gagne N; Kucher T; Thompson M; Bentley D
J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):45-55. PubMed ID: 30558730
[TBL] [Abstract][Full Text] [Related]
25. Characteristics and outcomes of stent occlusion after iliocaval stenting.
Jayaraj A; Crim W; Knight A; Raju S
J Vasc Surg Venous Lymphat Disord; 2019 Jan; 7(1):56-64. PubMed ID: 30442577
[TBL] [Abstract][Full Text] [Related]
26. Long term follow-up of endo-vascular recanalization of chronic inferior vena cava occlusion secondary to inferior vena cava filters.
Partovi S; Kalva SP; Walker TG; Taj SM; Ganguli S
Vasa; 2017 Mar; 46(2):121-126. PubMed ID: 28247824
[TBL] [Abstract][Full Text] [Related]
27. Double-barrel iliocaval reconstruction using closed-cell dedicated venous stents.
Korff RA; Bishay VL; Fischman AM; Kim E; Nowakowski FS; Patel RS; Tadros RO; Ting W; Vouyouka AG; Lookstein RA
J Vasc Surg Venous Lymphat Disord; 2023 Mar; 11(2):331-338. PubMed ID: 35961632
[TBL] [Abstract][Full Text] [Related]
28. One-Year Results of Iliocaval Stenting.
Tosenovsky P
Ann Vasc Surg; 2019 Aug; 59():208-216. PubMed ID: 30826434
[TBL] [Abstract][Full Text] [Related]
29. Single-session inferior vena cava filter removal, recanalization, and endovenous reconstruction for chronic iliocaval thrombosis.
Desai KR; Xiao N; Karp J; Salem R; Rodriguez H; Eskandari M; Uddin OM; Lewandowski RJ
J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):176-183. PubMed ID: 30612972
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of the stenting across the iliocaval confluence in patients with iliac venous lesions.
Zhang X; Jing Y; Sang H; Chen Z; Sun Y; Li X
J Thromb Thrombolysis; 2019 Jan; 47(1):134-139. PubMed ID: 30328053
[TBL] [Abstract][Full Text] [Related]
31. Is it necessary to dilate stents in management of nonthrombotic iliac vein lesions?
Aurshina A; Ostrozhynskyy Y; Nguyen H; Alsheekh A; Marks N; Rajaee S; Hingorani A; Ascher E
J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):522-526. PubMed ID: 31203858
[TBL] [Abstract][Full Text] [Related]
32. The incidence of contralateral iliac venous thrombosis after stenting across the iliocaval confluence in patients with acute or chronic venous outflow obstruction.
Caliste XA; Clark AL; Doyle AJ; Cullen JP; Gillespie DL
J Vasc Surg Venous Lymphat Disord; 2014 Jul; 2(3):253-9. PubMed ID: 26993383
[TBL] [Abstract][Full Text] [Related]
33. Safety and efficacy of stenting nonthrombotic iliac vein lesions in octogenarians and nonagenarians in an office setting.
Kibrik P; Eisenberg J; Alsheekh A; Rizvi SA; Aurshina A; Marks N; Hingorani A; Ascher E
Vascular; 2018 Feb; 26(1):70-74. PubMed ID: 28728480
[TBL] [Abstract][Full Text] [Related]
34. Analysis of threshold stenosis by multiplanar venogram and intravascular ultrasound examination for predicting clinical improvement after iliofemoral vein stenting in the VIDIO trial.
Gagne PJ; Gasparis A; Black S; Thorpe P; Passman M; Vedantham S; Marston W; Iafrati M
J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):48-56.e1. PubMed ID: 29033314
[TBL] [Abstract][Full Text] [Related]
35. Endovascular Iliocaval Stent Reconstruction for Inferior Vena Cava Filter-Associated Iliocaval Thrombosis: Approach, Technical Success, Safety, and Two-Year Outcomes in 120 Patients.
Chick JFB; Jo A; Meadows JM; Abramowitz SD; Khaja MS; Cooper KJ; Williams DM
J Vasc Interv Radiol; 2017 Jul; 28(7):933-939. PubMed ID: 28527883
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of anticoagulant and antiplatelet therapy after iliocaval stenting: Factors associated with stent occlusion.
Attaran RR; Ozdemir D; Lin IH; Mena-Hurtado C; Lansky A
J Vasc Surg Venous Lymphat Disord; 2019 Jul; 7(4):527-534. PubMed ID: 31203859
[TBL] [Abstract][Full Text] [Related]
37. Factors affecting outcome of open and hybrid reconstructions for nonmalignant obstruction of iliofemoral veins and inferior vena cava.
Garg N; Gloviczki P; Karimi KM; Duncan AA; Bjarnason H; Kalra M; Oderich GS; Bower TC
J Vasc Surg; 2011 Feb; 53(2):383-93. PubMed ID: 21146346
[TBL] [Abstract][Full Text] [Related]
38. Treatment of iliac-caval outflow obstruction.
Raju S
Semin Vasc Surg; 2015 Mar; 28(1):47-53. PubMed ID: 26358309
[TBL] [Abstract][Full Text] [Related]
39. Complications with office-based venoplasties and stenting and their clinical correlation.
Ganelin A; Hingorani A; Ascher E; Kheyson B; Iadgarova E; Marks N; Ostrozhynskyy Y
J Vasc Surg Venous Lymphat Disord; 2015 Oct; 3(4):376-379. PubMed ID: 26992614
[TBL] [Abstract][Full Text] [Related]
40. Demographic and clinical features do not affect the outcome of combined endovenous therapy to treat leg swelling.
Alsheekh A; Hingorani A; Aurshina A; Kibrik P; Marks N; Ostrozhynskyy Y; Ascher E
Vascular; 2018 Oct; 26(5):472-476. PubMed ID: 29473448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
